ADPKD=autosomal dominant polycystic kidney disease.
*Based on data collected from 4 different studies.
†Based on the historical average annual estimated glomerular filtration rate decrease among pediatric patients (n=16/23) enrolled in the CARDINAL trial.
The severity of Alport syndrome makes early detection critical. Considering Alport syndrome when patients present with declining glomerular filtration rate—particularly when accompanied by hematuria and/or a family history of CKD/AS—may help accurately identify the condition sooner.1,2,8-11
Confirming an Alport syndrome diagnosis sooner is possible with genetic testing
Genetic testing for Alport syndrome and several other rare forms of chronic kidney disease is more accessible than ever before. Find out the eligibility requirements for no-charge genetic testing through KIDNEYCODE.
You are now leaving Alportsyndrome.com
You are leaving alportsyndrome.com and connecting to a site that is not under the control of Reata Pharmaceuticals, Inc. (“Reata”).
Reata is not responsible for the contents of any such site or any further links from such site. Reata is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by Reata.